Presented by Jeannie Gorman, MS, CCN | June 3, 2026 at 12 PM Pacific

This webinar will explore how the GI360™ provides a comprehensive view of the microbiome and dysbiosis, with insights into GLP-1 signaling pathways. Learn practical applications for patients with GI, autoimmune, cardiovascular, neurological, or skin conditions, and discover how stool insights can guide better clinical outcomes.

Learning Objectives:

• Describe the GI360™ complimentary methodologies and applications
• Identify patients who benefit from stool testing
• Interpret markers of dysbiosis and GLP-1-modulating bacteria
• Apply targeted probiotics, soluble fiber, diet, and dysbiosis therapies to support microbiome health and GLP-1 signal pathways
• Explain the role of retesting for optimizing microbiome and GLP-1-related outcomes